Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2110 of 6351
-
DNA vaccine aims to train body to fight breast cancer
Vaccine OngoingThe purpose of this research study is to find out about the safety of injecting the gene (DNA) for mammaglobin-A into people with breast cancer. The DNA used in this study was purified from bacteria and contains the gene for mammaglobin-A. Mammaglobin-A is a protein that is highl…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Vaccine
Last updated Jun 27, 2026 12:23 UTC
-
New PET scan may predict breast cancer drug success
Diagnosis OngoingThis pilot clinical trial studies how well copper Cu 64-tetra-azacyclododecanetetra-acetic acid (DOTA)-trastuzumab positron emission tomography (PET) works in predicting response to treatment with ado-trastuzumab emtansine in patients with human epidermal growth factor receptor 2…
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Glowing dye could help surgeons spot hidden lung cancer spread
Diagnosis Recruiting nowThis is a clinical trial to evaluate the use of peritumoral injection of near-infrared dye indocyanine green to identify lung lesions and sentinel lymph nodes. The primary purpose is to determine if the use of ICG injected via navigational bronchoscopy, CT-guided or transthoracic…
Phase 1/2 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
Lung cancer breakthrough: chemo spares Low-Risk patients
Knowledge-focused CompletedBrief Summary The goal of this clinical trial is to evaluate the effect of postoperative adjuvant chemotherapy (ACT) in patients with stage I non-squamous non-small cell lung cancer (NSCLC) after curative resection. The main questions it aims to answer are: Does ACT improve rec…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Can electrical pulses outsmart chronic neck pain?
Symptom relief CompletedThe aim of this study was to determine and compare the efficacy of transcutaneous electrical nerve stimulation (TENS), interferential current (IFC), and sham therapy in patients with chronic neck pain. A total of 57 patients diagnosed with chronic mechanical neck pain were inclu…
Sponsor: Beylikduzu State Hospital • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
New diabetes combo shows promise in japanese study
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of co-administration of Teneligliptin (MP-513) and Canagliflozin (TA-7284) once daily for 24 weeks in Japanese patients with Type 2 diabetes mellitus who are receiving treatment with Teneligliptin and have inadequat…
Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New vaccine aims to fight childhood brain tumors without surgery
Disease control Recruiting nowThe study will assess the immunogenicity, safety and preliminary clinical efficacy of the glioma associated antigen (GAA)/tetanus toxoid (TT) peptide vaccine and poly-ICLC in HLA-A2+ children with unresectable low-grade gliomas that have received at least two chemotherapy/biologi…
Phase 2 • Sponsor: James Felker • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can we predict who will relapse after brain inflammation?
Knowledge-focused CompletedThis study focuses on a rare brain disease called anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis. In this condition, the body's immune system mistakenly attacks a protein in the brain, which can cause problems with memory, thinking, behavior, and seizures. While most …
Sponsor: Shen Chun-Hong • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Dialysis danger: a new model aims to predict sudden blood pressure crashes
Knowledge-focused CompletedThe main objective is to establish a statistical predictive model of the risk of intradialytic hypotension during hemodialysis (HD) or hemodiafiltration (HDF) sessions based on the measurement of residual blood volume and excess extracellular hydration. The secondary objective is…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Epidurals and infections: a 49,000-Birth investigation
Knowledge-focused OngoingThe goal of this retrospective observational cohort study is to explore the associations between neuraxial labor analgesia and maternal-neonatal infectious outcomes among women attempting vaginal delivery, and to distinguish genuine infectious risks from clinical fever-related di…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Could a simple screw choice reduce orthodontic complications?
Disease control CompletedEvidence for the undeniable role of microscrews in anchorage control, as well as their other advantages, such as ease of insertion and removal techniques, have led to their routine use in orthodontics. Treatment with microscrews, despite its obvious advantages, is associated with…
Sponsor: Wroclaw Medical University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
One-Shot radiation hope for bulky tumors
Symptom relief Recruiting nowPalliative radiation therapy represents 40% of the on-going radiation at the Jewish General Hospital. In a traditional palliative radiation treatment to bulky or radioresistant tumors, radiotherapy schema varies from 24 to 30 Gys given in 3 to 10 fractions, depending on the tumor…
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Can a drug combo shrink liver tumors enough for surgery?
Disease control CompletedBACKGROUND: For patients with liver-limited metastatic colorectal cancer (mCRC), complete resection of liver metastases is the only potentially curative treatment. The current goal of medical treatment for colorectal cancer with initially unresectable liver metastases is to maxi…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Frozen hope: new study protects fertility in young cancer patients
Knowledge-focused Recruiting nowBackground: Due to the remarkable improvement in treatments these last decades, long term survival can be expected in more than 80% of childhood cancer patients. Unfortunately, cancer treatments can be harmful to the gonads and can affect reproductive and endocrine functions. Wh…
Sponsor: Gumy-Pause Fabienne • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Radiation's hidden toll on the brain: new study maps cognitive changes to protect patients
Knowledge-focused Recruiting nowIn this proposal, the investigators introduce a novel, translational study to prospectively examine primary brain tumor patients undergoing fractionated radiation therapy to the brain. Quantitative neuroimaging, radiation dose information, and directed neurocognitive testing will…
Sponsor: Jona Hattangadi-Gluth • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Can a simple score prevent unnecessary hospital stays for chest pain?
Knowledge-focused CompletedChest pain remains one of the most common, potentially serious presenting complaints for adults emergency department visits with approximately 7.6 million yearly visits in the united states. The priority for emergency physician is to determine whether these patients with acute ch…
Sponsor: University of Monastir • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New IV drug shows promise for kids with stubborn arthritis
Disease control CompletedThe purpose of this study is to evaluate the pharmacokinetics (the study of the way a drug enters and leaves the blood and tissues over time) of golimumab administered intravenously (IV) to pediatric participants with polyarticular (affects 5 or more joints) juvenile (an onset be…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
MRI as a window into bone marrow disease: a new biomarker test?
Knowledge-focused Recruiting nowThis study is for the development and validation of functional magnetic resonance imaging (MRI) parameters as biomarkers for analyzing extent of disease and quantifying response to treatment in patients with myelofibrosis.
Sponsor: University of Michigan Rogel Cancer Center • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Promising combo tackles tough blood cancers in early trial
Disease control CompletedTo evaluate the safety and preliminary efficacy of acalabrutinib in combination with obinutuzumab in 4 separate cohorts of participants.
Phase 1 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug combo shows promise for Hard-to-Treat blood cancers
Disease control CompletedThis study is evaluating the safety, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy acalabrutinib and ACP 319 in B-cell malignancies.
Phase 1/2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC